The Bioethics Shared Resource (BESR), coordinated through the Tuskegee University National Center for Bioethics in Health Care Research, provides exceptional bioethics education, training, guidance, and consultation forthe MSM/TU/UABCCC Partnership. BESR activities fall under two overarching and complementary objectives: (a) achieving competencies in content areas of bioethics, having especially to do with research ethics, and (b) integrating bioethics concepts throughout the Partnership by dialogue with researchers, clinicians, professors, students, mentors, community health advisors, patient navigators, recruiters, and key personnel. Achieving appropriate bioethical competencies and integration ensures that cancer research, outreach, mentoring, and partnering with underserved or minority communities follow ethical guidelines.
Specific Aims are: 1. To provide education, mentoring, and training in bioethics for mentors, faculty, fellows, graduate and undergraduates students, community partners, and other key partnership personnel. 2. To coordinate and teach the Tuskegee University graduate/undergraduate course in bioethics. health disparities and health policy. 3. To instruct and coordinate the continuing yearly course. Bioscience Research and Ethics, for graduate students. 4. To provide review of research projects from design to implementation. 5. To evaluate bioethics education and training needs of all elements of the Partnership, in collaboration with the Cancer Education Program. 6. To collaborate in overall guidance and leadership ofthe Partnership. 7. To collaborate with other Partnership members in conducting and reporting empirical research and publishing scholariy works in relevant bioethics journals as well as lay publications. 8. To collaborate with Partnership members in securing funding for bioethics research, service, and educational activities.

Agency
National Institute of Health (NIH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118638-09
Application #
8728759
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Morehouse School of Medicine
Department
Type
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30310
Samuel, Temesgen; Fadlalla, Khalda; Gales, Dominique N et al. (2014) Variable NF-?B pathway responses in colon cancer cells treated with chemotherapeutic drugs. BMC Cancer 14:599
Battle, Monica; Gillespie, Corey; Quarshie, Alexander et al. (2014) Obesity induced a leptin-Notch signaling axis in breast cancer. Int J Cancer 134:1605-16
Singh, Rajesh; Gupta, Pranav; Kloecker, Goetz H et al. (2014) Expression and clinical significance of CXCR5/CXCL13 in human non?small cell lung carcinoma. Int J Oncol 45:2232-40
Desai, Arpita; Xu, Jingyao; Aysola, Kartik et al. (2014) Epithelial ovarian cancer: An overview. World J Transl Med 3:1-8
Colbert, Laronna S; Wilson, Kaamilah; Kim, Sungjin et al. (2014) NILCO biomarkers in breast cancer from Chinese patients. BMC Cancer 14:249
Smith, Selina A; Blumenthal, Daniel S (2013) Efficacy to effectiveness transition of an Educational Program to Increase Colorectal Cancer Screening (EPICS): study protocol of a cluster randomized controlled trial. Implement Sci 8:86
Coleman Wallace, Debbie A; Baltrus, Peter T; Wallace, Tracey C et al. (2013) Black white disparities in receiving a physician recommendation for colorectal cancer screening and reasons for not undergoing screening. J Health Care Poor Underserved 24:1115-24
Qin, Yunlong; Xu, Jingyao; Aysola, Kartik et al. (2011) Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins. J Cell Physiol 226:3355-67
Caplan, Lee; Stout, Charlotte; Blumenthal, Daniel S (2011) Training physicians to do office-based smoking cessation increases adherence to PHS guidelines. J Community Health 36:238-43
Fortson, Wendell S; Kayarthodi, Shubhalaxmi; Fujimura, Yasuo et al. (2011) Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. Int J Oncol 39:111-9

Showing the most recent 10 out of 13 publications